The Healing Better campaign has been made possible through generous in-kind contributions from the following sponsors: Rethink, Global BC,
Canada Wide Media, Barlow Media, Outsider Editorial, Alter Ego, Sequioa Films, Katharine Petkovski, ACTRA, Kalum Ko, and Wave Productions.
with certain types of CF. Dr.
Quon's next research phase
involves growing patient nasal
cells in the lab and testing their
response to Trikafta—work that
could expand access to the drug
and lead to future treatments for
those who don't benefit from it.
"Ultimately, we want to make CF
stand for 'cure found'," he says.
Trina spent most of her life planning her
funeral. Now, she's able to plan her future.
Since beginning Trikafta, Trina says life has never been
better. She hasn't been hospitalized. She can travel,
breathe, live. And she's finally pursuing her
childhood passion: she's a veterinary assistant at
an animal clinic.
"The whole cystic fibrosis team is amazing. They treat
me like family—I've always felt seen and taken care of."
Helping patients breathe again:
Dr. Bradley Quon and Trikafta
St. Paul's Hospital is home to the
largest adult cystic fibrosis clinic
in the province, and its clinicians
are working on a cure for this
challenging disease. Every year of
research adds a year of life to the
patients living with CF.
Clinician-scientists like Dr. Bradley
Quon are paving the way for life-
Dr. Quon, clinician-scientist, medical director of the CF Adult Care Program, and
researcher at the Centre for Heart and Lung Innovation, has devoted his career
to helping patients embark on a path to Healing Better.
Since Trikafta's discovery, St. Paul's Hospital hasn't
performed a single lung transplant for CF patients.
"I wouldn't be here if it weren't for research," she
says. "I really wasn't able to live before Trikafta, and
all the people behind it. You can't put a price on the
difference St. Paul's Hospital makes in people's lives."
Trina's story is a powerful reminder of what's
possible when compassionate care, research, and
innovation come together. At St. Paul's Hospital,
that's Healing Better.
changing treatments—and an
eventual cure. In 2018, he led a
clinical trial for Trikafta that showed
dramatic improvements in patient
lung function, quality of life, and
reduced hospitalizations. The trial
helped secure Trikafta's approval
in Canada and today, the drug is
widely available—helping thousands
of Canadians breathe easier.
While Trikafta is a transformational
drug, it's only approved for people
100,045
EMERGENCY
DEPARTMENT VISITS
1,239
BABIES
BORN
139
KIDNEY
TRANSPLANTS
553,606
PATIENT
VISITS
718
OPEN HEART
SURGERIES
27
HEART
TRANSPLANTS*
St. Paul's Hospital 2025: THE NUMBERS BEHIND OUR CARE
*St. Paul's Hospital is the only facility in B.C. to perform adult heart transplants
